Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,850 | 10,488 | 13,311 | 16,429 | 4,236 |
| TOTAL | $18,184 | $11,093 | $13,952 | $17,114 | $5,016 |
| Non-Current Assets | |||||
| PPE Net | 493 | 517 | 543 | 192 | 212 |
| Intangibles | 0 | 0 | 0 | 1,676 | 1,676 |
| Other Non-Current Assets | 460 | 939 | 559 | 559 | 93 |
| TOTAL | $952 | $1,456 | $1,102 | $2,426 | $1,981 |
| Total Assets | $19,136 | $12,549 | $15,054 | $19,541 | $6,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,528 | 2,055 | 1,544 | 2,572 | 2,094 |
| Other current liabilities | 46 | 47 | 43 | 86 | 152 |
| TOTAL | $2,674 | $2,200 | $1,622 | $2,661 | $2,289 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 33 | N/A | 40 |
| Other Non-Current Liabilities | 476 | 502 | 171 | 0 | 0 |
| TOTAL | $476 | $502 | $171 | $N/A | $1 |
| Total Liabilities | $3,150 | $2,702 | $1,793 | $2,661 | $2,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31 | 18 | 16 | 16 | 12 |
| Retained earnings | -104,398 | -101,210 | -97,588 | -93,761 | -90,746 |
| TOTAL | $15,986 | $9,847 | $13,261 | $16,880 | $4,707 |
| Total Liabilities And Equity | $19,136 | $12,549 | $15,054 | $19,541 | $6,997 |